BALAXI PHARMACEUTICALS LIMITED (BALAXI) - Total Liabilities

Latest as of September 2025: Rs844.30 Million INR ≈ $9.13 Million USD

Based on the latest financial reports, BALAXI PHARMACEUTICALS LIMITED (BALAXI) has total liabilities worth Rs844.30 Million INR (≈ $9.13 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

BALAXI PHARMACEUTICALS LIMITED - Total Liabilities Trend (2013–2025)

This chart illustrates how BALAXI PHARMACEUTICALS LIMITED's total liabilities have evolved over time, based on quarterly financial data. See BALAXI working capital ratio to evaluate short-term liquidity relative to the company's equity base.

BALAXI PHARMACEUTICALS LIMITED Competitors by Total Liabilities

The table below lists competitors of BALAXI PHARMACEUTICALS LIMITED ranked by their total liabilities.

Company	Country	Total Liabilities
NSX Ltd AU:NSX	Australia	AU$6.20 Million
Wanted Lab Inc. KQ:376980	Korea	₩23.81 Billion
K Wave Media Ltd. NASDAQ:KWM	USA	$101.67 Million
Intrusion Inc NASDAQ:INTZ	USA	$4.24 Million
NetX Holdings Bhd KLSE:0020	Malaysia	RM34.86 Million
Klimator AB ST:KLIMAT	Sweden	Skr20.33 Million
MSCM Holdings Bhd KLSE:0041	Malaysia	RM78.65 Million
Euromedis Groupe SA PA:ALEMG	France	€23.04 Million

Liability Composition Analysis (2013–2025)

This chart breaks down BALAXI PHARMACEUTICALS LIMITED's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BALAXI company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BALAXI PHARMACEUTICALS LIMITED's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BALAXI PHARMACEUTICALS LIMITED (2013–2025)

The table below shows the annual total liabilities of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs786.06 Million ≈ $8.50 Million	+37.96%
2024-03-31	Rs569.79 Million ≈ $6.16 Million	+0.33%
2023-03-31	Rs567.89 Million ≈ $6.14 Million	-10.29%
2022-03-31	Rs633.07 Million ≈ $6.85 Million	+82.44%
2021-03-31	Rs347.00 Million ≈ $3.75 Million	+321.88%
2020-03-31	Rs82.25 Million ≈ $889.51K	+217.90%
2019-03-31	Rs25.87 Million ≈ $279.81K	+1859.33%
2018-03-31	Rs1.32 Million ≈ $14.28K	-39.26%
2017-03-31	Rs2.17 Million ≈ $23.51K	+5061.73%
2016-03-31	Rs42.12K ≈ $455.50	-7.73%
2015-03-31	Rs45.65K ≈ $493.67	-98.92%
2014-03-31	Rs4.24 Million ≈ $45.88K	-12.73%
2013-03-31	Rs4.86 Million ≈ $52.57K	--

About BALAXI PHARMACEUTICALS LIMITED

NSE:BALAXI India Drug Manufacturers - Specialty & Generic

Market Cap

$14.13 Million

Rs1.31 Billion INR

Market Cap Rank

#26169 Global

#1455 in India

Share Price

Rs23.67

Change (1 day)

+0.47%

52-Week Range

Rs15.67 - Rs50.27

All Time High

Rs207.74